tradingkey.logo

Pfizer Inc

PFE
View Detailed Chart

22.930USD

+0.149+0.66%
Close 04/25, 16:00ETQuotes delayed by 15 min
129.94BMarket Cap
16.18P/E TTM

Pfizer Inc

22.930

+0.149+0.66%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.66%

5 Days

+3.57%

1 Month

-9.04%

6 Months

-19.40%

Year to Date

-13.57%

1 Year

-9.72%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 23 analysts
HOLD
Current Rating
29.128
Target Price
27.09%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
8
Average
Company name
Ratings
Analysts
Pfizer Inc
PFE
23
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
32

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(3)
Buy(4)
Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.194
Neutral
RSI(14)
42.730
Neutral
STOCH(KDJ)(9,3,3)
74.963
Buy
ATR(14)
0.907
Low Volatility
CCI(14)
70.522
Neutral
Williams %R
41.444
Buy
TRIX(12,20)
-0.629
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
22.376
Buy
MA10
22.198
Buy
MA20
23.050
Sell
MA50
24.843
Sell
MA100
25.527
Sell
MA200
27.094
Sell

Company

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Company codePFE
CompanyPfizer Inc
CEODr. Albert Bourla, Ph.D.
Websitehttps://www.pfizer.com/